Co-Authors
This is a "connection" page, showing publications co-authored by Alfonso Tafur and Eduardo Ramacciotti.
Connection Strength
0.573
-
Medically Ill hospitalized Patients for COVID-19 THrombosis Extended ProphyLaxis with rivaroxaban ThErapy: Rationale and Design of the MICHELLE Trial. Am Heart J. 2021 12; 242:115-122.
Score: 0.241
-
Evidence-Based Practical Guidance for the Antithrombotic Management in Patients With Coronavirus Disease (COVID-19) in 2020. Clin Appl Thromb Hemost. 2020 Jan-Dec; 26:1076029620936350.
Score: 0.215
-
The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper. Thromb Haemost. 2021 Aug; 121(8):992-1007.
Score: 0.060
-
An Update on the Pathogenesis of COVID-19 and the Reportedly Rare Thrombotic Events Following Vaccination. Clin Appl Thromb Hemost. 2021 Jan-Dec; 27:10760296211021498.
Score: 0.058